Designing a novel mRNA vaccine against Vibrio harveyi infection in fish: an immunoinformatics approach

• Published in: Genomics & informatics Vol. 20; no. 1; p. e11
• Main Authors: Islam, Sk Injamamul, Mou, Moslema Jahan, Sanjida, Saloa, Tariq, Muhammad, Nasir, Saad, Mahfuj, Sarower
• Format: Journal Article
• Language: English
• Published: Korea (South) Korea Genome Organization 01.03.2022
• Subjects: Original; vaccine design; Vibrio harveyi; T-cell epitopes; molecular dynamics simulation; immune simulation
• ISSN: 1598-866X; 2234-0742; 2234-0742
• DOI: 10.5808/gi.21065

Vibrio harveyi belongs to the family Vibrionaceae of class Gammaproteobacteria. Around 12 Vibrio species can cause gastroenteritis (gastrointestinal illness) in humans. A large number of bacterial particles can be found in the infected cells, which may cause death. Despite these devastating complications, there is still no cure or vaccine for the bacteria. As a result, we used an immunoinformatics approach to develop a multi-epitope vaccine against the most pathogenic hemolysin gene of V. harveyi. The immunodominant T- and B-cell epitopes were identified using the hemolysin protein. We developed a vaccine employing three possible epitopes: cytotoxic T-lymphocytes, helper T-lymphocytes, and linear B-lymphocyte epitopes, after thorough testing. The vaccine was developed to be antigenic, immunogenic, and non-allergenic, as well as have a better solubility. Molecular dynamics simulation revealed significant structural stiffness and binding stability. In addition, the immunological simulation generated by computers revealed that the vaccination might elicit immune reactions Escherichia coli K12 as a model, codon optimization yielded ideal GC content and a higher codon adaptation index value, which was then included in the cloning vector pET2+ (a). Altogether, our experiment implies that the proposed peptide vaccine might be a good option for vibriosis prophylaxis.